Avalo Therapeutics, Inc. (AVTX)

NASDAQ: AVTX · Real-Time Price · USD

16.71

-0.39 (-2.28%)

At close: Mar 12, 2026, 4:00 PM EDT

16.46

-0.25 (-1.50%)

After-hours: Mar 12, 2026, 7:45 PM EDT

Avalo Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Cash & Equivalents	26.96	134.55	7.42	13.17	54.59	18.92
Short-Term Investments	84.65	-	-	-	-	-
Cash & Short-Term Investments	111.62	134.55	7.42	13.17	54.59	18.92
Cash Growth	36.35%	1714.51%	-43.71%	-75.87%	188.52%	424.15%
Accounts Receivable	-	-	-	-	1.06	2.18
Other Receivables	-	-	0.14	1.92	3.74	2.21
Total Trade Receivables	-	-	0.14	1.92	4.8	4.39
Inventory	-	-	-	0.02	0.04	0
Other Current Assets	2.23	4.34	0.84	1.31	2.42	2.7
Total Current Assets	113.85	138.89	8.4	16.42	61.85	26.01
Net Property, Plant & Equipment	0.54	1.21	1.97	2.41	2.7	1.61
Other Intangible Assets	-	-	-	-	0.04	1.59
Goodwill	10.5	10.5	10.5	14.41	14.41	14.41
Other Long-Term Assets	0.21	0.13	0.13	0.13	1.23	0.15
Total Assets	125.1	150.73	20.99	33.37	80.21	43.76
Accounts Payable	0.47	0.28	0.45	2.88	3.37	2.57
Accrued Expenses	7.5	6.32	4.17	13.21	16.52	11.31
Short-Term Debt	-	-	-	5.93	-	-
Unearned Revenue	-	-	-	0.09	-	-
Other Current Liabilities	-	0.36	-	-	-	1.34
Total Current Liabilities	7.97	6.96	4.62	22.11	19.89	15.23
Long-Term Debt	-	-	-	13.49	32.83	-
Other Long-Term Liabilities	25.58	10.74	9.07	8.68	4.41	3.97
Total Long-Term Liabilities	25.58	10.74	9.07	22.17	37.24	3.97
Total Liabilities	33.55	17.7	13.69	44.28	57.13	19.19
Preferred Stock	-	-	-	-	-	0
Common Stock	0.02	0.01	0	0	0.01	0.08
Additional Paid-in Capital	526.29	503.29	342.44	292.91	285.24	202.28
Accumulated Other Comprehensive Income	0.04	-	-	-	-	-
Retained Earnings	-434.8	-370.26	-335.13	-303.82	-262.17	-177.79
Shareholders' Equity	91.55	133.03	7.3	-10.92	23.08	24.56
Total Liabilities & Equity	125.1	150.73	20.99	33.37	80.21	43.76
Total Debt	-	0	0	19.42	32.83	0
Net Cash (Debt)	111.62	134.55	7.42	-6.24	21.75	18.92
Net Cash Growth	-17.04%	1714.51%	-	-	14.97%	424.15%
Net Cash Per Share	0.02	35.99	26.70	-0.16	647.71	823.14
Book Value	91.55	133.03	7.3	-10.92	23.08	24.56
Book Value Per Share	0.02	35.59	26.30	-0.28	687.31	1068.66
Tangible Book Value	81.05	122.53	-3.2	-25.32	8.64	8.57
Tangible Book Value Per Share	0.02	32.78	-11.51	-0.65	257.12	372.78

Updated Nov 6, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q